Epidural Steroid Injection

Overview

An epidural steroid injection (ESI) delivers anti-inflammatory corticosteroid medication, usually combined with a numbing agent, directly into the epidural space, the area surrounding the spinal cord and nerve roots. The goal is to reduce inflammation and swelling around an irritated nerve, which can significantly ease pain that radiates into the arm or leg. It is a treatment for symptoms, not a cure for the underlying disc herniation, stenosis, or degenerative change causing them.

There are three main ways to reach the epidural space: interlaminar, transforaminal, and caudal. All three use image guidance, most often fluoroscopy (real-time X-ray), to place the needle accurately and confirm correct medication spread with a small amount of contrast dye before the steroid is injected. The choice of approach depends on the location and pattern of the patient's symptoms, prior spine surgery, and physician judgment, and each has a somewhat different balance of precision, area of coverage, and risk.

When it's recommended

ESIs are most often recommended for radiculopathy, nerve root pain that radiates into an arm or leg, caused by a herniated disc, spinal stenosis, or a bone spur pressing on a nerve. They are typically considered after a trial of conservative treatment such as activity modification, physical therapy, and oral medication has not provided enough relief, and before or alongside a decision about whether surgery is needed. They are also frequently used for patients who are not surgical candidates or who want to delay or avoid surgery.

ESIs are less consistently helpful for pain confined to the back or neck alone (axial pain) without nerve root involvement, and they are not a treatment for muscle strain or mechanical pain unrelated to a compressed or inflamed nerve. Your clinician will typically want imaging, such as an MRI, that shows a nerve-level cause consistent with your symptoms before recommending the injection.

How it works

Interlaminar injections approach the epidural space from directly behind, passing the needle between two vertebral laminae (the bony arches of the spine) into the space overlying the spinal cord and nerves. This approach spreads medication over a broader area and is technically the most straightforward, but it is less precise about which specific nerve root receives the medication.

Transforaminal injections approach through the small bony opening (foramen) where a specific nerve root exits the spine, allowing medication to be delivered close to that nerve. This targeted delivery can mean more concentrated treatment of the exact level causing symptoms, though it requires careful needle positioning near blood vessels that run alongside the nerve.

Caudal injections enter through the sacral hiatus, a small natural opening near the tailbone, and the medication flows upward into the lower epidural space. This route avoids the area directly over the spinal cord and is often preferred in patients who have had prior lumbar surgery with scar tissue, or when a lower, wider entry point is safer than one closer to the level of concern.

In all three approaches, the physician confirms needle position with fluoroscopic imaging and a small injection of contrast dye to verify it flows into the epidural space (and not into a blood vessel or the spinal fluid) before the steroid and numbing medication are injected.

Preparing for the procedure

Most patients are asked to arrange a ride home, since some clinics offer mild sedation and driving is not advised for several hours afterward regardless. Blood thinners, aspirin, and certain supplements often need to be paused beforehand on your physician's instructions, and you should bring an updated list of medications and allergies, including any prior reaction to contrast dye or steroids. Patients with diabetes should know that the steroid can temporarily raise blood sugar for a few days and should plan monitoring accordingly. Light eating is often permitted, but follow your clinic's specific fasting instructions, especially if sedation is planned.

Recovery and aftercare

The numbing medication typically wears off within a few hours, during which the injected area may feel temporarily numb or mildly weak; most clinics recommend taking it easy for the rest of the day and resuming normal activity the next day unless told otherwise. Pain relief from the steroid, when it occurs, usually builds over three to seven days as the anti-inflammatory effect takes hold, and it is common to feel little change immediately or even a brief flare beforehand. Ice, acetaminophen, and rest can help manage soreness at the injection site in the first day or two.

If the injection provides meaningful relief, physical therapy is typically introduced or intensified during this window to build strength and mobility while pain is reduced. A series of up to about three injections, spaced roughly two or more weeks apart, is a common approach, with each additional injection generally reserved for patients who saw at least partial benefit from the last one. Injections that provide no benefit are usually not repeated.

Risks and considerations

ESIs are generally considered a low-risk procedure with a long track record of use, though they are not without complications. Common, usually self-limited effects include temporary soreness at the injection site, a brief increase in pain, facial flushing, and temporary elevation of blood sugar in patients with diabetes. Less common risks include infection, bleeding, a dural puncture causing a spinal headache that is worse when upright and better lying flat, and, particularly with the transforaminal approach, injury to a nerve or blood vessel near the needle path.

The FDA has issued a safety communication noting that, in rare cases, epidural corticosteroid injection has been associated with serious neurologic events, including stroke, paralysis, and loss of vision, and that epidural use of these medications is technically an off-label application not specifically approved by the agency. These events are rare, and the choice of approach, needle type, and steroid formulation are all factors physicians weigh to reduce this risk. Because ESIs treat inflammation around a nerve rather than the structural cause of compression, symptoms can return over time, and some patients ultimately go on to consider surgery if conservative treatment, including injections, does not provide durable relief.